Ra medical systems, inc. (RMED)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Dec'17
ASSETS
Current Assets
Cash and cash equivalents

18,437

14,584

14,512

11,787

55,129

64,315

4,915

8,237

Short-term investments

5,003

15,993

25,964

36,601

-

-

-

-

Accounts receivable, net

684

786

1,296

1,454

1,292

1,320

1,346

517

Inventories

2,773

2,777

2,572

2,344

2,217

2,097

1,281

1,196

Prepaid expenses and other current assets

1,792

1,860

1,108

1,302

1,815

1,501

237

92

Total current assets

28,689

36,000

45,452

53,488

60,453

69,233

7,779

10,042

Property and equipment, net

4,687

5,050

5,418

5,767

5,530

4,757

2,809

1,159

Operating lease right-of-use-assets

2,749

2,835

2,919

3,002

3,084

-

-

-

Other non-current assets

175

196

213

217

213

45

3,601

68

TOTAL ASSETS

36,300

44,081

54,002

62,474

69,280

74,035

14,189

11,269

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable

1,356

1,532

1,004

1,515

1,411

1,125

3,340

426

Accrued expenses

2,082

2,642

4,386

2,074

1,061

2,809

1,640

324

Current portion of deferred revenue

1,964

2,029

1,917

2,039

1,954

1,723

-

1,714

Current portion of deferred revenue

-

-

-

-

-

-

1,751

-

Current portion of equipment financing

293

293

366

367

367

293

30

44

Current portion of operating lease liabilities

327

318

309

300

292

-

-

-

Other current liabilities

-

-

-

-

-

-

72

125

Total current liabilities

6,022

6,814

7,982

6,295

5,085

5,950

6,833

2,633

Deferred revenue

1,082

1,232

1,161

992

943

767

-

775

Deferred revenue

-

-

-

-

-

-

768

-

Equipment financing

189

265

417

510

594

557

-

19

Operating lease liabilities

2,533

2,620

2,701

2,782

2,861

-

-

-

Stock-based compensation liability

-

-

-

-

-

-

-

15,376

Other liabilities

-

-

-

-

-

56

107

81

Total liabilities

9,826

10,931

12,261

10,579

9,483

7,330

7,708

18,884

Commitments and contingencies (Note 11)

-

-

-

-

-

-

0

-

Stockholders’ Equity
Common stock, $0.0001 par value, 300,000,000 shares authorized; 13,895,349 and 13,770,349 issued and outstanding at March 31, 2020 and December 31, 2019, respectively

1

1

1

1

1

1

1

1

Additional paid-in capital

151,327

150,280

149,116

141,839

134,670

126,925

51,764

21,773

Accumulated deficit

-124,858

-117,157

-107,414

-89,996

-74,874

-60,221

-45,284

-29,389

Accumulated other comprehensive income

4

26

38

51

-

-

-

-

Total stockholders’ equity

26,474

33,150

41,741

51,895

59,797

66,705

6,481

-7,615

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

36,300

44,081

54,002

62,474

69,280

74,035

14,189

11,269